HY-100128-10mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-100mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-25mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-5mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-50mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100195-10mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
HY-100195-25mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
HY-100195-5mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
HY-100195-50mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
HY-100208-10mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-100mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-25mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-5mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-50mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100223-10mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-100mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-25mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-5mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-50mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100269-1mg
|
MedChemexpress LLC
|
Chymase-IN-1 [CAS 862090-74-2]
|
|
COVID-19-immunoregulation
|
|
HY-100272-1mg
|
MedChemexpress LLC
|
B220 [CAS 112228-65-6]
|
|
Cancer-programmed cell death
|
|
HY-100369A-10mg
|
MedChemexpress LLC
|
DMCM (hydrochloride) [CAS 1215833-62-7]
|
|
Cancer-programmed cell death
|
|
HY-100369A-100mg
|
MedChemexpress LLC
|
DMCM (hydrochloride) [CAS 1215833-62-7]
|
|
Cancer-programmed cell death
|
|
HY-100369A-25mg
|
MedChemexpress LLC
|
DMCM (hydrochloride) [CAS 1215833-62-7]
|
|
Cancer-programmed cell death
|
|
HY-100369A-5mg
|
MedChemexpress LLC
|
DMCM (hydrochloride) [CAS 1215833-62-7]
|
|
Cancer-programmed cell death
|
|